American Century Companies
PNT

American Century Companies’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

American Century Companies’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-794,611
Closed -$5.3M – 2943
2023
Q3 		$5.3M Buy
794,611
+416,006
+110% +$3.46M ﹤0.01% 1307
2023
Q2 		$3.43M Buy
378,605
+356,261
+1,594% +$3.14M ﹤0.01% 1447
2023
Q1 		$155K Buy
22,344
+9,446
+73% +$70.1K ﹤0.01% 2468
2022
Q4 		$94K Buy
12,898
+1,247
+11% +$9.25K ﹤0.01% 2463
2022
Q3 		$90K Buy
+11,651
New +$98.9K ﹤0.01% 2350

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

American Century Companies's PNT Position: Q4 2023 in Review

American Century Companies sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 794,611 shares — an estimated $5.3M sold.

American Century Companies first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $5.3M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • American Century Companies reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • American Century Companies sold 794,611 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.3M.
  • American Century Companies first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • American Century Companies's POINT Biopharma Global Inc. Common Stock position peaked at $5.3M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.